Literature DB >> 19181785

Myelofibrotic transformation in essential thrombocythemia.

Juergen Thiele, Hans Michael Kvasnicka.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19181785      PMCID： PMC2649360          DOI： 10.3324/haematol.2008.001446

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.

Authors:  Ada Maria Florena; Claudio Tripodo; Emilio Iannitto; Rossana Porcasi; Sabrina Ingrao; Vito Franco
Journal:  Haematologica       Date:  2004-08       Impact factor: 9.941

Review 2.  Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.

Authors:  J Thiele; H M Kvasnicka
Journal:  Histol Histopathol       Date:  2006-12       Impact factor: 2.303

3.  Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

Authors:  Claire N Harrison; Peter J Campbell; Georgina Buck; Keith Wheatley; Clare L East; David Bareford; Bridget S Wilkins; Jon D van der Walt; John T Reilly; Andrew P Grigg; Paul Revell; Barrie E Woodcock; Anthony R Green
Journal:  N Engl J Med       Date:  2005-07-07       Impact factor: 91.245

4.  Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.

Authors:  Umberto Gianelli; Claudia Vener; Paola Rafaniello Raviele; Alessia Moro; Federica Savi; Claudio Annaloro; Francesco Somalvico; Franca Radaelli; Vito Franco; Giorgio Lambertenghi Deliliers
Journal:  Leuk Lymphoma       Date:  2006-09

Review 5.  Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.

Authors:  S Murphy; P Peterson; H Iland; J Laszlo
Journal:  Semin Hematol       Date:  1997-01       Impact factor: 3.851

6.  European consensus on grading bone marrow fibrosis and assessment of cellularity.

Authors:  Jürgen Thiele; Hans Michael Kvasnicka; Fabio Facchetti; Vito Franco; Jon van der Walt; Attilio Orazi
Journal:  Haematologica       Date:  2005-08       Impact factor: 9.941

7.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors:  Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

8.  Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.

Authors:  G Barosi; R A Mesa; J Thiele; F Cervantes; P J Campbell; S Verstovsek; B Dupriez; R L Levine; F Passamonti; J Gotlib; J T Reilly; A M Vannucchi; C A Hanson; L A Solberg; A Orazi; A Tefferi
Journal:  Leukemia       Date:  2007-08-30       Impact factor: 11.528

9.  Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients.

Authors:  Francisco Cervantes; Alberto Alvarez-Larrán; Carme Talarn; Marta Gómez; Emilio Montserrat
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

10.  Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.

Authors:  J Thiele; H M Kvasnicka
Journal:  Ann Hematol       Date:  2003-02-22       Impact factor: 3.673
View more
  1 in total

1.  Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm.

Authors:  David C A Molitor; Peter Boor; Andreas Buness; Rebekka K Schneider; Lino L Teichmann; Ruth-Miriam Körber; Gabor L Horvath; Steffen Koschmieder; Ines Gütgemann
Journal:  Ann Hematol       Date:  2020-10-26       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.